27 results on '"Manenti, S."'
Search Results
2. Radioactive waste management in a general hospital with a nuclear medicine department with cyclotron
3. Activity size distribution of radioactive nuclide 7Be at different locations and under different meteorological conditions
4. PO-422 Development of an ALK lymphoma-derived autophagosomal and dendritic cells vaccine
5. Phytotoxicity of ionic, micro- and nano-sized iron in three plant species
6. SPH Based Approach toward the Simulation of Non-cohesive Sediment Removal by an Innovative Technique Using a Controlled Sequence of Underwater Micro-explosions
7. 845: The ROS/SUMO axis is involved in acute myeloid leukemia (AML) cells response to chemotherapeutic drugs and constitutes a potential target to overcome chemoresistance in AML
8. EP-1412: Image guided adaptive radiotherapy: A practical method to estimate rectal and bladder dose in prostate treatment
9. An air-mass trajectory study of the transport of radioactivity from Fukushima to Thessaloniki, Greece and Milan, Italy
10. R88: Impact du nombre de cellules leucémiques chimiorésistantes CD34+CD38-CD123+ sur la réponse au traitement et la survie de patients atteints de leucémie aiguë myéloïde
11. R54: Activité de l’inhibiteur sélectif de la sous-unité p110 alpha de la PI3-kinase dans les leucémies aiguës myéloïdes
12. R23: L’oncogène JAK2 V617F induit une dérégulation de CDC25A, phosphatase clé du cycle cellulaire, dans la maladie de Vaquez
13. R18: Expression, rôle et régulation épigénétique de la forme courte de Ron dans les leucémies aiguës myéloïdes (LAM)
14. R8 – Oral Un rôle pour l’inhibition de la sumoylation par les ROS dans la chimiorésistance des leucémies aiguës myéloïdes ?
15. Dietary protein-induced proctocolitis in childhood
16. Prokinetic effect of Alka-Seltzer in healthy subjects
17. Prokinetic effect of alka-seltzer in healthy subjects
18. Plasma chromogranin a in multiple endocrine neoplasia type 1 and gut neuroendocrine tumors
19. P 146 Cloning of cyclin H from human corneal keratocytes association with its catalytic partner MO15 to form the CDK-activating kinase CAK
20. Immunolocalization of the myristoylated alanine-rich C kinase substrate (MARCKS) in human corneal keratocytes.
21. P 147 Immunolocalization of the myristoylated alanine-rich C kinase substrate (MARCKS) in human corneal keratocytes
22. A mass spectrometric study on the in vivo posttranslational modification of GAP-43.
23. Myristoylated alanine-rich C kinase substrate (MARCKS), a major protein kinase C substrate, is an in vivo substrate of proline-directed protein kinase(s). A mass spectroscopic analysis of the post-translational modifications
24. Demyristoylation of the major substrate of protein kinase C (MARCKS) by the cytoplasmic fraction of brain synaptosomes.
25. Interaction of myristoylated alanine-rich protein kinase C substrate (MARCKS) with membrane phospholipids
26. Isolation of the non-myristoylated form of a major substrate of protein kinase C (MARCKS) from bovine brain.
27. Affinity purification and characterization of myristoylated alanine-rich protein kinase C substrate (MARCKS) from bovine brain. Comparison of the cytoplasmic and the membrane-bound forms.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.